eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 33 | 29 | −4 |
| Shares | 24.4M | 23.5M | −965.1K (−4.0%) |
| Value | $20.2M | $14.0M | −$6.19M (−30.7%) |
New holders (5)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sonora Investment Management Group, LLC | 125,000 | $75.0K | 0.01% |
| Stifel Financial Corp | 22,660 | $13.6K | 0.00% |
| UBS Group AG | 9,874 | $5.92K | 0.00% |
| Barclays PLC | 82 | $49 | 0.00% |
| JPMorgan Chase & Co | 30 | $18 | 0.00% |
Sold out (9)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Two Sigma Investments, LP | 81,558 | $67.7K |
| HRT Financial LP | 31,023 | $25.0K |
| XTX Topco Ltd | 28,826 | $23.9K |
| Prudential Financial Inc | 13,200 | $11.0K |
| Simplex Trading, LLC | 10,119 | $8.00K |
| Virtu Financial LLC | 10,140 | $8.00K |
| Advisor Group Holdings, Inc. | 1,500 | $1.33K |
| ICA Group Wealth Management, LLC | 1,100 | $914 |
| Bank of America Corp | 100 | $83 |